Different expression of mimecan as a marker for differential diagnosis between NSCLC and SCLC

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1057-1061

  Zheng, Cui Xia ^a   Zhao, Shuang Xia ^a   Wang, Ping ^b   Yu, Hui Min ^a   Wang, Cao Fu ^b   Han, Bing ^a   Su, Bin ^a   Xiang, Yi ^a   Li, Xue Song ^a   Li, Sheng Xian ^a   Ma, Qin Yun ^a   Zhang, Rong Xin ^b   Wan, Huan Ying ^a   Song, Huai Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BENGBU MEDICAL COLLEGE   (China)

Author keywords

Differential diagnosis; Mimecan; Molecular biomarker; Non small cell lung cancers; Small cell lung cancers

Indexed keywords

MIMECAN; POLYCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; BRONCHUS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EPITHELIUM CELL; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG ALVEOLUS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NORTHERN BLOTTING; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA ANALYSIS; TISSUE DISTRIBUTION;

BLOTTING, NORTHERN; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; PROGNOSIS; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 70449366248     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000536     Document Type: Article

References (24)

1. Bentz H, Nathan RM, Rosen DM, Armstrong RM, Thompson AY, Segarini PR, Mathews MC, Dasch JR, Piez KA and Seyedin SM: Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem 264: 20805-20810, 1989.
2. Bentz H, Thompson AY, Armstrong R, Chang RJ, Piez KA and Rosen DM: Transforming growth factor-beta 2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and 3 Matrix 11: 269-275, 1991.
3. Funderburgh JL, Corpuz LM, Roth MR, Funderburgh ML, Tasheva ES and Conrad GW: Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin. J Biol Chem 272: 28089-28095, 1997.
4. Tasheva ES, Corpuz LM, Funderburgh JL and Conrad GW: Differential splicing and alternative polyadenylation generate multiple mimecan mRNA transcripts. J Biol Chem 272: 32551-32556, 1997.
5. Madisen L, Neubauer M, Plowman G, Rosen D, Segarini P, Dasch J, Thompson A, Ziman J, Bentz H and Purchio AF: Molecular cloning of a novel bone-forming compound: osteoinductive factor. DNA Cell Biol 9: 303-309, 1990.
6. Ujita M, Shinomura T and Kimata K: Molecular cloning of the mouse osteoglycin-encoding gene. Gene 158: 237-240, 1995.
7. Funderburgh JL and Conrad GW: Isoforms of corneal keratan sulfate proteoglycan. J Biol Chem 265: 8297-8303, 1990.
8. Funderburgh JL, Funderburgh ML, Mann MM and Conrad GW: Unique glycosylation of three keratan sulfate proteoglycan isoforms. J Biol Chem 266: 14226-14231, 1991.
9. Kukita A, Bonewald L, Rosen D, Seyedin S, Mundy GR and Roodman GD: Osteoinductive factor inhibits formation of human osteoclast-like cells. Proc Natl Acad Sci USA 87: 3023-3026, 1990.
10. Tasheva ES, Maki CG, Conrad AH and Conrad GW: Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site. Biochim Biophys Acta 1517: 333-338, 2001.
11. Tasheva ES, Koester A, Paulsen AQ, Garrett AS, Boyle DL, Davidson HJ, Song M, Fox N and Conrad GW: Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol Vis 8: 407-415, 2002.
12. Tasheva ES: Analysis of the promoter region of human mimecan gene. Biochim Biophys Acta 1575: 123-129, 2002.
13. Hu SM, Li F, Yu HM, Li RY, Ma QY, Ye TJ, Lu ZY, Chen JL and Song HD: The mimecan gene expressed in human pituitary and regulated by pituitary transcription factor-1 as a marker for diagnosing pituitary tumors. J Clin Endocrinol Metab 90: 6657-6664, 2005.
14. Molina R, Filella X and Auge JM: ProGRP: a new biomarker for small cell lung cancer. Clin Biochem 37: 505-511, 2004.
15. Tarro G, Perna A and Esposito C: Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol 203: 1-5, 2005.
16. Niklinski J, Furman M, Laudanski J and Kozlowski M: Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer. Eur J Cancer Prev 1: 401-406, 1992.
17. Molina R, Filella X, Auge JM, Fuentes R, Bover I, Rifa J, Moreno V, Canals E, Viñolas N, Marquez A, Barreiro E, Borras J and Viladiu P: Tumour markers (CEA, CA125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as aid in histological diagnosis and prognosis: comparison with the main clinical and pathological prognostic factors. Tumor Biol 24: 209-218, 2003.
18. Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Ohe Y, Kakinuma R and Kodama T: Significance of serum progastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen. Lung Cancer 27: 159-167, 2000.
19. Lamy PJ, Grenier J, Kramar A and Pujol JL: Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. Lung Cancer 29: 197-203, 2000.
20. Hage R, Elbers HR, Brutel de la Rivière A and van den Bosch JM: Neural cell adhesion molecule expression: prognosis in 889 patients with resected non-small cell lung cancer. Chest 114: 1316-1320, 1998.
21. Ando S, Kimura H, Iwai N, Shima M, Ando M and Kuriyama T: Optimal combination of seven tumor markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Anticancer Res 21: 3085-3092, 2001.
22. Lantuejoul S, Moro D, Michalides RJ, Brambilla C and Brambilla E: Neural cell adhesion molecule (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 22: 1267-1276, 1998.
23. Kibbelaar RE, Moolenaar KE, Michalides RJ, Van Bodegom PC, Vanderschueren RG, Wagenaar SS, Dingemans KP, Bitter-Suermann D, Dalesio O and Van Zandwijk N: Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 24: 431-435, 1991.
24. Kaufmann O, Georgi T and Dietel M: Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. Hum Pathol 28: 1373-1378, 1997.